Acquired defects of fibrinolysis associated with thrombosis.
about
Management of thrombotic and cardiovascular disorders in the new millenium.Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary EmbolismThe effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity.
P2860
Acquired defects of fibrinolysis associated with thrombosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Acquired defects of fibrinolysis associated with thrombosis.
@ast
Acquired defects of fibrinolysis associated with thrombosis.
@en
type
label
Acquired defects of fibrinolysis associated with thrombosis.
@ast
Acquired defects of fibrinolysis associated with thrombosis.
@en
prefLabel
Acquired defects of fibrinolysis associated with thrombosis.
@ast
Acquired defects of fibrinolysis associated with thrombosis.
@en
P2093
P356
P1476
Acquired defects of fibrinolysis associated with thrombosis.
@en
P2093
P304
P356
10.1055/S-2007-994940
P577
1999-01-01T00:00:00Z